Stockscreener 앱 받기
278.44
0.85%
-2.39
시간 외 거래:
278.44
전일 마감가:
$280.83
열려 있는:
$280.27
하루 거래량:
518.57K
Relative Volume:
0.75
시가총액:
$20.03B
수익:
$2.96B
순이익/손실:
$487.70M
주가수익비율:
41.71
EPS:
6.6758
순현금흐름:
$344.00M
1주 성능:
+1.20%
1개월 성능:
-0.64%
6개월 성능:
+25.72%
1년 성능:
-16.27%
1일 변동 폭
$276.08
$281.38
1주일 범위
$269.55
$291.38
52주 변동 폭
$187.43
$348.90
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
278.44 | 20.20B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
592.27 | 210.16B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.71 | 58.51B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.02 | 40.19B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
248.21 | 36.37B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.43 | 31.30B | 27.43B | 1.27B | 1.01B | 1.5829 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
KeyBanc Sees Injectable GLP-1s Driving Ongoing Demand for WST - Finviz
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
14 Best Dividend Growth Stocks to Buy and Hold in 2026 - Insider Monkey
2026 world cup star players tips: Is West Pharmaceutical Services Inc. stock dividend yield sustainable2026 world cup usa national team round of 32 playmakers low block defense group prediction guide - ulpravda.ru
West Pharmaceutical Services Inc Stock Price Live, Charts & News - The Economic Times
West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 25% Upside Potential - DirectorsTalk Interviews
Who Owns West Pharmaceutical Services? Top Shareholders and Recent Insider Trades - TIKR.com
Investing in West Pharmaceutical Services (NYSE:WST) three years ago would have delivered you a 20% gain - simplywall.st
West Pharmaceutical Services, Inc. $WST Shares Acquired by North Growth Management Ltd. - MarketBeat
2 Safe-and-Steady Stocks with Solid Fundamentals and 1 We Question - Finviz
Biotech’s New Edge: 5 Companies Mastering "How" We Dose - The Globe and Mail
Ethic Inc. Purchases 4,206 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin - MSN
Cwm LLC Purchases 14,789 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Acquired by Annex Advisory Services LLC - MarketBeat
What analysts say about West Pharmaceutical Services Inc stockShort-Term Trading Alerts & Small Entry Capital Stocks - earlytimes.in
West Pharmaceutical Services Earnings Notes - Trefis
West Pharma heads to JPMorgan healthcare stage as investors watch closely - MSN
The Biotech Revolution’s Ultimate ‘Picks and Shovels’ Play: A Deep Dive into West Pharmaceutical Services (WST) - FinancialContent
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
Madrigal Heads to JPMorgan as MASH Drug Puts Company in the Spotlight - MyChesCo
Picks and Shovels of the Biotech Revolution: A Deep Dive into West Pharmaceutical Services (WST) - FinancialContent
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Riverbridge Partners LLC Cuts Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Position Decreased by Seilern Investment Management Ltd - MarketBeat
West Pharmaceutical Services (BIT:1WST) Price Target Increased by 11.94% to 309.57 - Nasdaq
Texas Permanent School Fund Corp Has $2.44 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript - MSN
West Pharmaceutical Services (NYSE:WST) Stock Rating Upgraded by Wall Street Zen - MarketBeat
How risky is West Pharmaceutical Services Inc. stock now2025 Market WrapUp & Weekly Market Pulse Updates - Улправда
West Pharma Heads to JPMorgan Healthcare Stage as Investors Watch Closely - MyChesCo
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $340 From $345, Maintains Buy Rating - marketscreener.com
Will West Pharmaceutical Services Inc. stock benefit from AI adoptionEarnings Summary Report & Scalable Portfolio Growth Methods - DonanımHaber
Will West Pharmaceutical Services Inc. stock benefit from infrastructure spendingMarket Performance Summary & Free Fast Entry Momentum Trade Alerts - DonanımHaber
Thrivent Financial for Lutherans Reduces Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Corient Private Wealth LLC Sells 6,498 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
ProRx Bets on Robots and Clean Rooms as Demand for Compounded Drugs Surges - MyChesCo
West Pharma declares dividend as Exton giant signals steady footing - MSN
West Pharma Declares Dividend as Exton Giant Signals Steady Footing - MyChesCo
Will West Pharmaceutical Services Inc. stock draw ESG focused funds2025 Risk Factors & Real-Time Volume Surge Alerts - Улправда
Is West Pharmaceutical Services Inc. stock dividend yield sustainable2025 Market WrapUp & Free Weekly Watchlist of Top Performers - Улправда
Assenagon Asset Management S.A. Purchases 35,408 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Stock: Is WST Underperforming the Healthcare Sector? - Yahoo Finance
West Pharmaceutical Services (WST): Reassessing Valuation After a 20% Share Price Decline - Yahoo Finance
West Pharmaceutical Services (WST) Gets a Hold from Barclays - The Globe and Mail
Caxton Associates LLP Makes New $1.61 Million Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by Pitcairn Co. - MarketBeat
Investor Optimism Abounds West Pharmaceutical Services, Inc. (NYSE:WST) But Growth Is Lacking - 富途牛牛
Hilton Capital Management LLC Has $1.93 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by Liontrust Investment Partners LLP - MarketBeat
Headlands Technologies LLC Boosts Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
0.50%
자본화:
|
볼륨(24시간):